Possible scenario
AI-Bio Program Advances
40% Chance
The $6 billion initiative is implemented as a White House-led AI-for-science and biomedical data program, building on the October 7 bio-dataset push with Big Tech. NIH, DOE, NSF and OSTP coordinate awards around foundation models for drug discovery, genomics, materials science and national-lab computing.
Secondary impacts
- Technology +0.9%
- Healthcare +0.6%
- Business Services +0.3%
- Industrials +0.2%
Tickers
- NVDA+1.8%
- MSFT+1.3%
- +1.0%
Portfolio impact
S&P 500+0.6%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.